Arctis Global »

Atara Biotherapeutics shares owned by Arctis Global

Quarter-by-quarter ownership of Atara Biotherapeutics (ATRA) shares owned by Arctis Global from 13F filings

Historical chart of Arctis Global investment in Atara Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Atara Biotherapeutics held by Arctis Global consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atara Biotherapeutics by Arctis Global

Quarter filed Position value Share count Share price at filing
2023-09-30 $588k 397k 1.48

More positions owned by Arctis Global

Ishares Msci Brazil Etf (EWZ)
Select Sector Spdr Tr Energy (XLE)
Ishares Tr Msci Emg Mkt Etf (EEM)
Rekor Systems (REKR)
Spdr Ser Tr S&p Oilgas Exp (XOP)
Teck Resources CL B (TECK)
Global X Fds Global X Uranium (URA)
Pan American Silver Corp Can Call Option (PAAS)
Lockheed Martin Corporation (LMT)
First Horizon National Corporation (FHN)
Ftai Aviation SHS (FTAI)
Atara Biotherapeutics (ATRA)
Iovance Biotherapeutics (IOVA)

View all positions for Arctis Global

Top funds holding Atara Biotherapeutics

EcoR1 Capital
Redmile Group
Vanguard Group
UBS Group
AQR Capital Management
Millennium Management
Jpmorgan Chase & Co
D. E. Shaw & Co
Staley Capital Advisers
GSA Capital Partners
Jacobs Levy Equity Management
Charles Schwab Investment Management
Goldman Sachs Group
Bank of New York Mellon
Bnp Paribas Arbitrage, Snc

View all funds holding Atara Biotherapeutics